CAPROCK Group Inc. Buys 1,156 Shares of Colgate-Palmolive Company (CL)
CAPROCK Group Inc. increased its stake in Colgate-Palmolive Company (NYSE:CL) by 24.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,904 shares of the company’s stock after purchasing an additional 1,156 shares during the quarter. CAPROCK Group Inc.’s holdings in Colgate-Palmolive were worth $438,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in CL. American Beacon Advisors Inc. bought a new stake in Colgate-Palmolive during the first quarter valued at about $102,000. Proficio Capital Partners LLC raised its holdings in Colgate-Palmolive by 16.9% during the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after acquiring an additional 207 shares during the period. OLD Second National Bank of Aurora bought a new stake in Colgate-Palmolive during the second quarter valued at about $109,000. Harbour Capital Advisors LLC bought a new stake in Colgate-Palmolive during the first quarter valued at about $121,000. Finally, Hanson & Doremus Investment Management raised its holdings in Colgate-Palmolive by 4.5% during the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares during the period. 73.10% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/28/caprock-group-inc-buys-1156-shares-of-colgate-palmolive-company-cl.html.
In other Colgate-Palmolive news, COO Justin Skala sold 74,374 shares of the stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now owns 97,177 shares in the company, valued at approximately $7,046,304.27. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director John T. Cahill sold 8,000 shares of the stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $72.47, for a total transaction of $579,760.00. Following the completion of the sale, the director now owns 31,786 shares of the company’s stock, valued at approximately $2,303,531.42. The disclosure for this sale can be found here. In the last quarter, insiders sold 217,969 shares of company stock valued at $15,693,933. 1.02% of the stock is owned by insiders.
A number of research firms have commented on CL. Bank of America Corporation raised their price target on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, May 31st. BidaskClub cut Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a report on Friday, June 30th. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a report on Tuesday, July 4th. Finally, Jefferies Group LLC raised their price target on Colgate-Palmolive from $76.00 to $77.00 and gave the company a “hold” rating in a report on Thursday, July 6th. One equities research analyst has rated the stock with a sell rating, fourteen have given a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $76.18.
Colgate-Palmolive Company (NYSE:CL) opened at 73.08 on Thursday. The stock’s 50 day moving average price is $71.58 and its 200-day moving average price is $73.27. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The stock has a market cap of $64.37 billion, a price-to-earnings ratio of 27.16 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.72. The company had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. Colgate-Palmolive’s quarterly revenue was down .5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.70 EPS. Equities analysts expect that Colgate-Palmolive Company will post $2.89 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be issued a $0.40 dividend. The ex-dividend date is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.20%. Colgate-Palmolive’s payout ratio is 59.48%.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.